跳至主要内容
临床试验/NCT02688634
NCT02688634撤回不适用

The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair

University of Florida2 个研究点 分布在 1 个国家开始时间: 2016年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Infection rates between the groups

研究概览

简要总结

Cleft Lip and Palate surgical repair is one of the most common procedures performed by Plastic and Reconstructive Surgeons in the World. With this in mind, it is curious that no consensus exists regarding the usage of postoperative antibiotics or the effects this might have on wound complications such as cellulitis, dehiscence, or fistula formation. The surgical bed in cleft lip/palate repair is known to harbor a myriad of pathological organisms, indeed the human bite is one of the more clinically and microbiologically significant injuries to treat. This research study is to elucidate the role, if any, that prophylactic antibiotics have in the prevention of complications post cleft palate (CP) and VPI repair and potentially establish a new paradigm of care.

详细描述

This will be a randomized prospective research study. Participants who will undergo an elective CP or VPI surgery will be randomized to receive either 1) antibiotics or 2) nothing postoperatively. All participants will be evaluated for infection, fistula formation, and dehiscence upon discharge and at 30-day follow-up based on standards of care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Month 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 1 month to 60 years
  • Subjects undergoing independently scheduled elective Cleft Palate of VPI repair
  • Do not meet any exclusion criteria

排除标准

  • Any repeat repair
  • Symptoms of upper respiratory infection
  • Immunosuppressed
  • Allergy to Amoxicillin or any other Penicillins
  • Antibiotic usage <2weeks prior to scheduled surgery other than immediate pre-operative antibiotics
  • Inability to follow up

研究组 & 干预措施

Treatment

Participants in this group are randomize to receive post-operative antibiotic of Amoxicillin x7 days, 20mg/kg orally every 6 hours to a maximum of 1.8g/day for a 7-day period. They will be evaluated for infection, fistula formation, and dehiscence upon discharge and at 30-day follow-up based on standards of care.

干预措施: Amoxicillin (Drug)

结局指标

主要结局

Infection rates between the groups

时间窗: 30 days

Analysis of infection is based on a 7 point scale to allow for broadened data but can be evaluated in a binary fashion for ≥ 4 indicating infection and \<4 as no infection. A χ2 test and Fisher's exact test for p\<0.05 will be used to determine significance of the difference in complication (cellulitis and upper respiratory infection) rates between the two groups.

Dehiscence and fistula formation between the groups

时间窗: 30 days

Both dehiscence and fistula formation will also be recorded as a binary present/not present data point to determine the significance of the difference in complication rates between the groups.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验